Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-26 Sale | 2025-03-28 4:07 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 46,551 | $95.62 | $4,451,084 | 288,314 (Direct) | View |
| 2025-03-13 Sale | 2025-03-17 9:51 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 11,637 | $96.04 | $1,117,566 | 532,549 (Direct) | View |
| 2025-03-10 Sale | 2025-03-11 5:40 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 2,731 | $94.73 | $258,695 | 53,578 (Direct) | View |
| 2025-01-29 Sale | 2025-01-31 5:46 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 1,657 | $78.48 | $130,046 | 23,307 (Direct) | View |
| 2025-01-07 Sale | 2025-01-10 5:53 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 51,420 | $94.48 | $4,858,119 | 1,720 (Direct) | View |
| 2025-01-02 Sale | 2025-01-06 6:05 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 18,006 | $78.18 | $1,407,686 | 53,140 (Direct) | View |
| 2024-12-16 Sale | 2024-12-18 6:22 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 10,501 | $76.75 | $805,995 | 239,896 (Direct) | View |
| 2024-12-09 Sale | 2024-12-11 7:19 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 3,661 | $76.37 | $279,598 | 115,269 (Direct) | View |
| 2024-11-15 Sale | 2024-11-19 7:05 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 45,415 | $70.41 | $3,197,684 | 60,011 (Direct) | View |
| 2024-10-29 Sale | 2024-10-31 5:13 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 2,154 | $66.6 | $143,456 | 128,670 (Direct) | View |
| 2024-09-16 Sale | 2024-09-18 4:28 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 10,501 | $37.59 | $394,733 | 291,206 (Direct) | View |
| 2024-09-09 Sale | 2024-09-11 8:10 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 3,639 | $33.33 | $121,288 | 154,376 (Direct) | View |
| 2024-07-29 Sale | 2024-07-31 4:40 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 2,154 | $33.54 | $72,245 | 119,668 (Direct) | View |
| 2024-06-17 Sale | 2024-06-18 5:17 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 7,683 | $28.31 | $217,506 | 297,080 (Direct) | View |
| 2024-06-10 Sale | 2024-06-11 4:13 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 2,652 | $24.92 | $66,088 | 145,228 (Direct) | View |
| 2024-04-29 Sale | 2024-04-30 4:30 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 6,325 | $11.04 | $69,808 | 106,861 (Direct) | View |
| 2024-03-18 Sale | 2024-03-19 4:15 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine CHIEF EXECUTIVE OFFICER | 8,559 | $10.59 | $90,661 | 291,698 (Direct) | View |
| 2024-03-12 Sale | 2024-03-13 4:24 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine CHIEF EXECUTIVE OFFICER | 2,618 | $9.2097 | $24,111 | 56,507 (Direct) | View |
| 2023-12-18 Sale | 2023-12-19 9:26 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 11,734 | $2.1594 | $25,338 | 296,328 (Direct) | View |
| 2023-12-11 Sale | 2023-12-12 4:06 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 3,673 | $1.6104 | $5,915 | 124,120 (Direct) | View |
| 2023-09-18 Sale | 2023-09-19 6:09 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 10,752 | $4.1619 | $44,749 | 305,189 (Direct) | View |
| 2023-09-11 Sale | 2023-09-12 6:42 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 2,675 | $4.624 | $12,369 | 119,795 (Direct) | View |
| 2023-06-20 Sale | 2023-06-21 4:05 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 7,965 | $6.3687 | $50,727 | 312,069 (Direct) | View |
| 2023-06-12 Sale | 2023-06-13 5:23 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 2,674 | $6.4898 | $17,354 | 111,685 (Direct) | View |
| 2023-05-16 Sale | 2023-05-18 7:21 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 8,685 | $6.4985 | $56,439 | 16,162 (Direct) | View |
| 2023-03-10 Sale | 2023-03-13 7:26 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 92,644 | $0.3598 | $33,333 | 3,549,077 (Direct) | View |
| 2022-11-28 Purchase | 2022-11-28 6:33 pm | Sema4 Holdings Corp. | SMFR | Stueland Katherine Chief Executive Officer | 185,185 | $0.54 | $100,000 | 185,185 (Direct) | View |
| 2021-06-14 Sale | 2021-06-16 5:51 pm | Invitae Corp | NVTA | Stueland Katherine Chief Commercial Officer | 20,340 | $31.6 | $642,679 | 214,231 (Direct) | View |
| 2021-04-14 Sale | 2021-04-15 8:07 pm | Invitae Corp | NVTA | Stueland Katherine Chief Commercial Officer | 19,893 | $39.87 | $793,209 | 189,871 (Direct) | View |
| 2021-03-15 Sale(A) | 2021-03-19 5:05 pm | Invitae Corp | NVTA | Stueland Katherine Chief Commercial Officer | 5,781 | $42.9 | $248,008 | 209,764 (Direct) | View |
| 2021-03-15 Sale | 2021-03-17 9:49 pm | Invitae Corp | NVTA | Stueland Katherine Chief Commercial Officer | 12,443 | $42.9 | $533,812 | 209,764 (Direct) | View |
| 2021-02-25 Sale | 2021-02-26 5:11 pm | Invitae Corp | NVTA | Stueland Katherine Chief Commercial Officer | 5,000 | $39.96 | $199,824 | 238,052 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-26 Exercise | 2025-03-28 4:07 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 80,000 | $0 | 288,314 (Direct) | View |
| 2025-03-16 Exercise | 2025-03-17 9:51 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 18,750 | $0 | 532,549 (Direct) | View |
| 2024-03-26 Option Award | 2025-03-17 9:51 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 367,684 | $0 | 532,549 (Direct) | View |
| 2025-03-09 Exercise | 2025-03-11 5:40 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 6,546 | $0 | 53,578 (Direct) | View |
| 2025-01-29 Exercise | 2025-01-31 5:46 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 3,874 | $0 | 23,307 (Direct) | View |
| 2024-12-16 Exercise | 2024-12-18 6:22 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 18,750 | $0 | 239,896 (Direct) | View |
| 2024-12-09 Exercise | 2024-12-11 7:19 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 6,547 | $0 | 115,269 (Direct) | View |
| 2024-10-29 Exercise | 2024-10-31 5:13 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 3,874 | $0 | 128,670 (Direct) | View |
| 2024-09-16 Exercise | 2024-09-18 4:28 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 18,750 | $0 | 291,206 (Direct) | View |
| 2024-09-09 Exercise | 2024-09-11 8:10 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 6,546 | $0 | 154,376 (Direct) | View |
| 2024-07-29 Exercise | 2024-07-31 4:40 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 3,874 | $0 | 119,668 (Direct) | View |
| 2024-06-16 Exercise | 2024-06-18 5:17 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 18,750 | $0 | 297,080 (Direct) | View |
| 2024-06-09 Exercise | 2024-06-11 4:13 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 6,546 | $0 | 145,228 (Direct) | View |
| 2024-04-29 Exercise | 2024-04-30 4:30 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 15,496 | $0 | 106,861 (Direct) | View |
| 2024-03-16 Exercise | 2024-03-19 4:15 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine CHIEF EXECUTIVE OFFICER | 18,750 | $0 | 291,698 (Direct) | View |
| 2024-03-09 Exercise | 2024-03-12 5:26 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine CHIEF EXECUTIVE OFFICER | 6,547 | $0 | 131,136 (Direct) | View |
| 2023-12-16 Exercise | 2023-12-19 9:26 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 18,750 | $0 | 296,328 (Direct) | View |
| 2023-12-09 Exercise | 2023-12-12 4:06 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 6,546 | $0 | 124,120 (Direct) | View |
| 2023-09-16 Exercise | 2023-09-19 6:09 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 18,750 | $0 | 305,189 (Direct) | View |
| 2023-09-09 Exercise | 2023-09-12 6:42 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 6,547 | $0 | 119,795 (Direct) | View |
| 2023-06-16 Exercise | 2023-06-21 4:05 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 18,750 | $0 | 312,069 (Direct) | View |
| 2023-06-09 Exercise | 2023-06-13 5:23 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 6,546 | $0 | 111,685 (Direct) | View |
| 2023-04-29 Exercise | 2023-05-02 8:34 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 511,364 | $0 | 2,354,028 (Direct) | View |
| 2023-04-26 Option Award | 2023-04-27 7:41 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 9,900,000 | $0 | 9,900,000 (Direct) | View |
| 2023-03-09 Exercise | 2023-03-13 7:26 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 216,033 | $0 | 3,549,077 (Direct) | View |
| 2022-12-09 Option Award | 2022-12-14 4:14 pm | N/A 2026-12-09 | Sema4 Holdings Corp. | SMFR | Stueland Katherine Chief Executive Officer | 3,456,536 | $0 | 3,456,536 (Direct) | View |
| 2022-05-02 Option Award(A) | 2022-05-06 7:03 pm | N/A 2032-05-01 | Sema4 Holdings Corp. | SMFR | Stueland Katherine Chief Executive Officer | 3,551,136 | $0 | 3,551,136 (Direct) | View |
| 2022-05-02 Option Award | 2022-05-04 8:30 pm | N/A 2032-05-01 | Sema4 Holdings Corp. | SMFR | Stueland Katherine Chief Executive Officer | 5,596,590 | $0 | 5,596,590 (Direct) | View |
| 2021-04-30 Option Award | 2021-05-04 5:29 pm | N/A 2031-04-30 | Invitae Corp | NVTA | Stueland Katherine Chief Commercial Officer | 67,900 | $0 | 257,771 (Direct) | View |
| 2021-03-15 Option Award | 2021-03-17 9:49 pm | N/A N/A | Invitae Corp | NVTA | Stueland Katherine Chief Commercial Officer | 5,781 | $42.9 | 209,764 (Direct) | View |
| 2021-03-12 Option Award | 2021-03-17 9:49 pm | N/A N/A | Invitae Corp | NVTA | Stueland Katherine Chief Commercial Officer | 24,936 | $0 | 209,764 (Direct) | View |
| 2021-02-25 Exercise | 2021-02-26 5:11 pm | N/A 2026-03-31 | Invitae Corp | NVTA | Stueland Katherine Chief Commercial Officer | 5,000 | $0 | 238,052 (Direct) | View |
| 2021-02-25 Exercise | 2021-02-26 5:11 pm | N/A N/A | Invitae Corp | NVTA | Stueland Katherine Chief Commercial Officer | 5,000 | $10.23 | 238,052 (Direct) | View |